104 related articles for article (PubMed ID: 478308)
1. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
2. Lack of efficacy of hydergine in Alzheimer's disease.
Posner JD; Landsberg L
N Engl J Med; 1991 Jan; 324(3):197-8. PubMed ID: 1984200
[No Abstract] [Full Text] [Related]
3. The effects of Hydergine on neurotransmitters.
Ermini M
Br J Clin Pract Suppl; 1985 Jun; 39():11-5. PubMed ID: 2864053
[No Abstract] [Full Text] [Related]
4. Ergots in the treatment of mental disorders of old age.
Gaitz CM; Hartford JT
Adv Biochem Psychopharmacol; 1980; 23():349-56. PubMed ID: 7395621
[No Abstract] [Full Text] [Related]
5. Hydergine in Alzheimer's disease.
Baer L; Jenike MA
J Geriatr Psychiatry Neurol; 1991; 4(2):122-3. PubMed ID: 1854422
[No Abstract] [Full Text] [Related]
6. [Are the so-called cerebroactive drugs really useful?].
Reubi F
Ther Umsch; 1985 Aug; 42(8):547-51. PubMed ID: 4049306
[No Abstract] [Full Text] [Related]
7. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of senile dementia.
Reisberg B; Ferris SH; Gershon S
Proc Annu Meet Am Psychopathol Assoc; 1980; 69():233-64. PubMed ID: 6997869
[No Abstract] [Full Text] [Related]
9. Ergoloid mesylates vs. Alzheimer's: the latest round.
Walker C
Geriatrics; 1990 Dec; 45(12):22, 24. PubMed ID: 2253892
[No Abstract] [Full Text] [Related]
10. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
11. Hydergine effect on prolactin and reaction time in dementia.
el Sobky A; el Shazly M; Darwish AK; Davies T; Griffin K; Keshavan MS
Biol Psychiatry; 1986 Oct; 21(12):1229-30. PubMed ID: 3756269
[No Abstract] [Full Text] [Related]
12. Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report.
Yesavage JA; Tinklenberg JR
Gerontology; 1981; 27(1-2):76-8. PubMed ID: 7215823
[No Abstract] [Full Text] [Related]
13. Novel pharmacologic approaches to the treatment of senile dementia of the Alzheimer's type (SDAT).
Reisberg B; London E; Ferris SH; Anand R; de Leon MJ
Psychopharmacol Bull; 1983; 19(2):220-5. PubMed ID: 6346374
[No Abstract] [Full Text] [Related]
14. Research design issues: antialuminum drug studies in Alzheimer's disease.
Shore D; Wyatt RJ
Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877
[TBL] [Abstract][Full Text] [Related]
15. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings].
Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J
Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644
[No Abstract] [Full Text] [Related]
16. The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis.
Gualtieri F; Dei S; Manetti D; Romanelli MN; Scapecchi S; Teodori E
Farmaco; 1995; 50(7-8):489-503. PubMed ID: 7669187
[No Abstract] [Full Text] [Related]
17. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
Golden R
Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
19. Treatment of Alzheimer's disease: a cautionary note.
Bowen DM; Sims NR; Benton JS; Curzon G; Davison AN; Neary D; Thomas DJ
N Engl J Med; 1981 Oct; 305(17):1016. PubMed ID: 7278915
[No Abstract] [Full Text] [Related]
20. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Acierno G
Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
